Achieve Life Sciences Inc (ACHV)
Healthcare
Biotechnology
6.30 $
-1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Achieve Life Sciences Inc (ACHV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -6.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.7 | -5.1 | -4.4 | -5.3 | -4.9 | -10 | -9.2 | -11 | -9.1 | -11 | -18 | -6.9 | -45 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | |
| 1.2 | 1.2 | 0.0 | 1.3 | 1.5 | 1.3 | 1.2 | 2.2 | 2.9 | 2.3 | 1.3 | -0.7 | 5.8 | |
| 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.1 | 0.0 | 0.1 | -0.7 | 1.5 | -0.8 | 1.4 | -0.7 | 0.6 | 0.6 | -4.8 | 4.1 | 0.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 0.0 | 0.0 | – | -47 | 13 | 12 | 11 | 6.7 | -13 | 0.7 | 14 | 9.0 | |
| 0.0 | – | 0.0 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.0 | – | – | – | 5.0 | – | – | |
| 15 | 0.0 | 0.0 | 56 | -0.2 | -8.1 | 0.7 | 0.0 | 41 | 4.0 | 6.3 | 0.0 | 52 | |
| 8.6 | -5.2 | -4.4 | 51 | -52 | -5.2 | 3.2 | 0.3 | 39 | -20 | -11 | 7.1 | 15 | |
| -6.7 | -5.2 | -4.4 | -5.3 | -4.9 | -10 | -9.2 | -11 | -9.1 | -11 | -18 | -6.9 | -45 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.